Ramdevbaba Solvent Ltd

Ramdevbaba Solvent Ltd

₹ 129 0.04%
22 Nov - close price
About

Founded in 2008, Ramdevbaba Solvent Limited produces and distributes physically refined rice bran oil.[1]

Key Points

Business Segments
A) Third Party Manufacturing[1] The Company manufactures, distributes, markets, and sells rice bran oil to FMCG companies like Mother Dairy Fruit & Vegetable Private Limited, Marico Limited, and Empire Spices and Foods Ltd.

  • Market Cap 285 Cr.
  • Current Price 129
  • High / Low 135 / 80.1
  • Stock P/E 18.3
  • Book Value 57.3
  • Dividend Yield 0.00 %
  • ROCE 16.6 %
  • ROE 21.6 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.5%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Edible Oil Industry: Solvent Extraction

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Sep 2023 Mar 2024 Sep 2024
346 295 392 402
336 283 379 388
Operating Profit 10 12 13 14
OPM % 3% 4% 3% 3%
4 2 5 3
Interest 3 5 5 4
Depreciation 1 2 2 2
Profit before tax 10 7 10 11
Tax % 26% 25% 28% 26%
8 6 8 8
EPS in Rs 166.99 10.96 4.63 3.64
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
105 124 349 424 583 698 686 793
104 123 337 410 566 679 661 767
Operating Profit 1 1 12 13 17 19 25 27
OPM % 1% 1% 3% 3% 3% 3% 4% 3%
0 0 1 2 2 9 7 8
Interest 0 0 3 4 5 6 10 9
Depreciation 0 0 3 4 5 2 4 5
Profit before tax 1 1 6 7 9 19 18 21
Tax % 0% 0% 19% 19% 22% 24% 26%
1 1 5 6 7 15 13 16
EPS in Rs 27.64 19.79 110.75 125.57 145.19 320.25 8.04 8.27
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 19%
5 Years: %
3 Years: 17%
TTM: 24%
Compounded Profit Growth
10 Years: 34%
5 Years: %
3 Years: 31%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 25%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3 4 5 5 5 16 22
Reserves 1 3 24 31 43 57 105
14 12 45 65 99 111 79
6 9 26 28 44 46 40
Total Liabilities 24 27 99 129 191 229 245
14 12 39 40 62 94 96
CWIP 0 0 0 12 28 3 10
Investments 0 0 0 0 0 8 8
10 14 60 77 101 125 131
Total Assets 24 27 99 129 191 229 245

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4 3 -3 3 11 5
-8 -1 -3 -18 -39 -19
3 -2 6 15 28 14
Net Cash Flow 0 1 -0 -0 0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 11 21 16 17 20 22
Inventory Days 39 26 29 40
Days Payable 16 16 19 20
Cash Conversion Cycle 11 21 39 28 31 41
Working Capital Days 12 12 28 30 30 42
ROCE % 4% 16% 20% 17%

Shareholding Pattern

Numbers in percentages

Apr 2024Sep 2024
61.09% 61.36%
5.10% 0.37%
5.29% 1.25%
28.52% 37.02%
0.00% 0.44%
No. of Shareholders 1,7331,337

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents